72 related articles for article (PubMed ID: 4048817)
1. Short-term tamoxifen treatment in benign breast diseases.
Cupceancu B
Endocrinologie; 1985; 23(3):169-77. PubMed ID: 4048817
[TBL] [Abstract][Full Text] [Related]
2. Combined tamoxifen-lynestrenol treatment in benign breast disease.
Cupceancu B
Endocrinologie; 1985; 23(4):265-72. PubMed ID: 4089504
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen responders selection by computerized contact thermography in benign breast disease.
Cupceancu B; Mogoş I; Cotruţă C
Endocrinologie; 1986; 24(2):115-22. PubMed ID: 3738400
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of benign breast pathology with bromocriptine].
Tolino A; Cardone A; Mastrantonio P; Chiacchio G
Riv Ital Ginecol; 1977; 58(5):371-8. PubMed ID: 555037
[No Abstract] [Full Text] [Related]
5. [The treatment of benign pathological conditions of the breasts with progesterone and progestogens. The results according to the type of breast condition (260 case records) (author's transl)].
Mauvais-Jarvis P; Sterkers N; Kuttenn F; Beauvais J
J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3):477-84. PubMed ID: 681701
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of advanced breast cancer with tamoxifen (author's transl)].
Alonso Muñóz A; Pérez Manga G; Moreno Esteban B; Muñóz Gómez S; Madrigal Alonso PL; Pérez Modrego S
Med Clin (Barc); 1980 Jul; 75(3):93-7. PubMed ID: 7401744
[TBL] [Abstract][Full Text] [Related]
8. Benign breast lesions in Eastern Nigeria.
Anyikam A; Nzegwu MA; Ozumba BC; Okoye I; Olusina DB
Saudi Med J; 2008 Feb; 29(2):241-4. PubMed ID: 18246234
[TBL] [Abstract][Full Text] [Related]
9. The establishment and operation of a computerized data bank in benign breast disease. (Preliminary results on 297 cases).
Cupceancu B; Cotruţă C
Endocrinologie; 1987; 25(3):167-77. PubMed ID: 3685847
[TBL] [Abstract][Full Text] [Related]
10. Oral contraception and breast pathology.
Ragni N; Boccardo E; Viglino S; Larosa E
Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer.
Markiewicz DA; Fox KR; Schultz DJ; Harris EE; Haas JA; Glick JH; Solin LJ
Cancer J Sci Am; 1998; 4(3):185-93. PubMed ID: 9612601
[TBL] [Abstract][Full Text] [Related]
13. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
Kaufmann M; Rody A
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):146-54. PubMed ID: 16621229
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent breast cancer responding to long-term administration of tamoxifen].
Yayoi E; Kobayashi T; Inaji H; Maeura Y; Mori T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1683-6. PubMed ID: 6433801
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
Budd GT; Adamson PC; Gupta M; Homayoun P; Sandstrom SK; Murphy RF; McLain D; Tuason L; Peereboom D; Bukowski RM; Ganapathi R
Clin Cancer Res; 1998 Mar; 4(3):635-42. PubMed ID: 9533531
[TBL] [Abstract][Full Text] [Related]
16. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
17. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea.
Pierzyński P; Swiatecka J; Oczeretko E; Laudański P; Batra S; Laudański T
Gynecol Endocrinol; 2006 Dec; 22(12):698-703. PubMed ID: 17162713
[TBL] [Abstract][Full Text] [Related]
18. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
Baum M; Buzdar A; Cuzick J; Forbes J; Houghton J; Howell A; Sahmoud T;
Cancer; 2003 Nov; 98(9):1802-10. PubMed ID: 14584060
[TBL] [Abstract][Full Text] [Related]
19. Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea.
Kim HJ; Lee JS; Park EH; Lim WS; Sei JY; Koh BS; Son BH; Ahn JH; Jeong KH; Kim SB; Ahn SH
Eur J Surg Oncol; 2009 Sep; 35(9):936-41. PubMed ID: 19269125
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
